You are here
Clinical Trials: Stroke and Related
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Ischemic Stroke
Interventions: Biological: MultiStem; Biological: Placebo
Sponsors: Athersys, Inc; Medpace, Inc.
Not yet recruiting
Interventions: Biological: MultiStem; Biological: Placebo
Sponsors: Athersys, Inc; Medpace, Inc.
Not yet recruiting
Conditions: Stroke, Acute; Thrombosis
Intervention: Procedure: mechanical thrombectomy
Sponsors: Society of Minimally Invasive Neurological Therapeutic Procedures; Pakistani Society of Neuroradiology; Middle east North Africa Stroke & interventional Neurotherapies Organization; Egyptian Stroke society; African Academy of neurology; Egyptian Society for Progenitor Cell Research
Recruiting
Intervention: Procedure: mechanical thrombectomy
Sponsors: Society of Minimally Invasive Neurological Therapeutic Procedures; Pakistani Society of Neuroradiology; Middle east North Africa Stroke & interventional Neurotherapies Organization; Egyptian Stroke society; African Academy of neurology; Egyptian Society for Progenitor Cell Research
Recruiting
Condition: Cerebrovascular Disorders
Intervention: Biological: exosome
Sponsor: Isfahan University of Medical Sciences
Not yet recruiting
Intervention: Biological: exosome
Sponsor: Isfahan University of Medical Sciences
Not yet recruiting
Conditions: Hemorrhagic Stroke; Intracerebral Hemorrhage
Intervention: Biological: MSC
Sponsor: Mayo Clinic
Recruiting
Intervention: Biological: MSC
Sponsor: Mayo Clinic
Recruiting
Condition: Stroke
Intervention: Device: TPAD (Tethered Pelvic Assist Device)
Sponsor: Columbia University
Recruiting - verified June 2017
Intervention: Device: TPAD (Tethered Pelvic Assist Device)
Sponsor: Columbia University
Recruiting - verified June 2017
Condition: Cerebral Infarction
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#); Drug: Aspirin Tablet
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified April 2017
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#); Drug: Aspirin Tablet
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified April 2017
Condition: Cerebral Infarction
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cell; Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017
Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cell; Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium
Sponsor: Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017
Condition: Hypoxic-Ischemic Encephalopathy
Intervention: Procedure: Umbilical Cord Milking
Sponsor: Jubilee Mission Medical College and Research Institute
Not yet recruiting - verified April 2017
Intervention: Procedure: Umbilical Cord Milking
Sponsor: Jubilee Mission Medical College and Research Institute
Not yet recruiting - verified April 2017
Condition: Neonatal Hypoxic-ischaemic Encephalopathy
Intervention: Drug: autologous cord blood stem cell
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Intervention: Drug: autologous cord blood stem cell
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Condition: Stroke
Interventions: Other: Adipose Derived Stem Cells; Other: Vehicle media
Sponsors: University Hospital, Grenoble; European Commission H2020 program; Univ Grenoble Alpes, France; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Servicio Andaluz de Salud, Spain; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
Interventions: Other: Adipose Derived Stem Cells; Other: Vehicle media
Sponsors: University Hospital, Grenoble; European Commission H2020 program; Univ Grenoble Alpes, France; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Servicio Andaluz de Salud, Spain; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting - verified July 2016
